SiDMAP

SiDMAP – Metabolomics for Drug Development

Skip to content
  • Home
  • About SiDMAP
    • Contact Us
    • Agi Hirshberg
    • Laszlo G. Boros, M.D.
    • Wai-Nang Paul Lee, M.D.
    • David Manheim
  • Technology
    • Targeted Tracer Fate Associations
    • Precursor/Product Isotope Matching
  • Applications
  • Products
  • Services
  • Publications
    • Metabolic Phenotyping
    • Targeted Tracer Fate Association Study (TTFAS)
    • SiDMAP Array
    • Proteomics
    • Pharmacology
    • Lipidomics
    • Mitochondrial Metabolism
    • Cancer Metabolism
    • Animal Studies
    • Clinical Studies
  • News
  • Order Services
← SiDMAP Collaboration With National Cancer Institute To Be Presented at The 2013 World Biotechnology Conference
Combined genomics and targeted tracer fate association approach utilized in characterizing stress response in cancer →

SiDMAP Collaboration with University of Utah School of Medicine Published in FASEB Journal

by admin Posted on March 28, 2013

Posted in news Tagged publication

This entry was posted in News. Bookmark the permalink.
← SiDMAP Collaboration With National Cancer Institute To Be Presented at The 2013 World Biotechnology Conference
Combined genomics and targeted tracer fate association approach utilized in characterizing stress response in cancer →

Comments are closed.

  • News

    • SiDMAP’s scientific advisor delivers talk showing single [1,2-13C2]-D-Glucose tracer cross-labels intracellular stearic acid and better traces mechanistic rosiglitazone response than what was obtained with extracellular [U-13C18]-stearate incubation in a separate study using HepG2 cells.
    • Targeted tracer fate association study finds links among metformin, cholesterol, K-ras and pancreatic cancer growth-control
    • Combined genomics and targeted tracer fate association approach utilized in characterizing stress response in cancer
    • SiDMAP Collaboration with University of Utah School of Medicine Published in FASEB Journal
    • SiDMAP Collaboration With National Cancer Institute To Be Presented at The 2013 World Biotechnology Conference
    • Global Metabolomics Market to Reach $863.8 Million by 2017, According to a New Report by Global Industry Analysts, Inc.
    • SiDMAP studies of two Amgen anti-diabetic agents demonstrate mechanisms of glucose homeostatis regulation and energy metabolism.
Home | 2990 S. Sepulveda Blvd. #300B
Los Angeles, CA 90064

Contact SIDMAP | Privacy Policy